BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1665201)

  • 1. Regulation of human tissue-type plasminogen activator gene transcription by epidermal growth factor and 3',5'-cyclic adenosine monophosphate.
    Medcalf RL; Schleuning WD
    Mol Endocrinol; 1991 Dec; 5(12):1773-9. PubMed ID: 1665201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor stimulates tissue plasminogen activator activity and messenger ribonucleic acid levels in cultured rat granulosa cells: mediation by pathways independent of protein kinases-A and -C.
    Galway AB; Oikawa M; Ny T; Hsueh AJ
    Endocrinology; 1989 Jul; 125(1):126-35. PubMed ID: 2544397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
    Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
    Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate.
    Bergonzelli GE; Kruithof EK; Medcalf RL
    Endocrinology; 1992 Sep; 131(3):1467-72. PubMed ID: 1354603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.
    Medcalf RL; Rüegg M; Schleuning WD
    J Biol Chem; 1990 Aug; 265(24):14618-26. PubMed ID: 2167321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of cAMP-responsive-element (CRE)-binding protein-1 and activating transcription factor-2 to a CRE-like element in the human tissue-type plasminogen activator (t-PA) gene promoter correlates with opposite regulation of t-PA by phorbol ester in HT-1080 and HeLa cells.
    Costa M; Medcalf RL
    Eur J Biochem; 1996 May; 237(3):532-8. PubMed ID: 8647095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of 3 beta-hydroxysteroid dehydrogenase and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3',5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells.
    Tremblay Y; Beaudoin C
    Mol Endocrinol; 1993 Mar; 7(3):355-64. PubMed ID: 8387158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct adenosine 3',5'-monophosphate and phorbol ester-responsive signal transduction pathways converge at the level of transcriptional activation by the interactions of DNA-binding proteins.
    Hoeffler JP; Deutsch PJ; Lin J; Habener JF
    Mol Endocrinol; 1989 May; 3(5):868-80. PubMed ID: 2547158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
    Kraiem Z; Sadeh O; Yosef M; Aharon A
    Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor but not insulin-like growth factor-I potentiates adenosine 3',5'-monophosphate-mediated chorionic gonadotropin secretion by cultured human choriocarcinoma cells.
    Ritvos O; Jalkanen J; Pekonen F; Stenman UH; Ranta T
    Endocrinology; 1988 Aug; 123(2):859-65. PubMed ID: 2840269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter.
    Costa M; Shen Y; Maurer F; Medcalf RL
    Eur J Biochem; 1998 Nov; 258(1):123-31. PubMed ID: 9851700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor, a phorbol ester, and 3',5'-cyclic adenosine monophosphate decrease the transcription of the luteinizing hormone/chorionic gonadotropin receptor gene in MA-10 Leydig tumor cells.
    Nelson S; Ascoli M
    Endocrinology; 1992 Aug; 131(2):615-20. PubMed ID: 1322276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW; Nilsen-Hamilton M
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
    J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells.
    Fang MA; Kujubu DA; Hahn TJ
    Endocrinology; 1992 Nov; 131(5):2113-9. PubMed ID: 1330491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
    Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
    Glia; 1992; 6(3):163-71. PubMed ID: 1335967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles.
    Heinrich R; Kraiem Z
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1839-44. PubMed ID: 9177393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
    Medcalf RL
    J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.